Posts Tagged 'type 2 diabetes'

Judge allows company to sell generic Actos

A U.S. District Judge has allowed a company to begin immediately selling generic Actos, despite resistance from the Food and Drug Administration (FDA). Watson Pharmaceuticals will begin marketing the generic version of the top-selling type II diabetes drug Actos, which has come under fire for health concerns.

Read more about the generic version of Actos…


Consumer Reports warns against generic version of Actos

Consumer Reports has warned readers against using a generic version of Actos recently approved by the Food and Drug Administration. The consumer awareness organization recommends that patients ask their doctors if using the brand-name diabetes drug Actos or its new generic equivalent is necessary, and recommends it only for patients who have no other options.

Read more about the generic version of Actos…

Already susceptible to bladder cancer, Actos increases risk in diabetes patients

A Canadian study has found that people who suffer from diabetes have a 40 percent higher risk of developing  bladder cancer. Research has solidified that Actos, a popular prescription drug used to treat type 2 diabetes, further increases this risk.

Read more about the connection between Actos and bladder cancer…

Actos may increase risk of macular edema

Type II diabetes drug Actos may substantially increase the risk of macular edema, according to new research published in the Archives of Internal Medicine. The risk of developing the eye condition was 230% greater up to 10 years after use among patients taking the diabetes medication.

Read more about Actos and macular edema…

The Diabetes Dilemma for Statin Users

We’re overdosing on cholesterol-lowering statins, and the consequence could be a sharp increase in the incidence of Type 2 diabetes. This past week, the Food and Drug Administration raised questions about the side effects of these drugs and developed new labels for these medications that will now warn of the risk of diabetes and memory loss.

Click here to read more…

Statins raise risk of Type 2 diabetes in older women, study finds

Older women who take statin medications like Zocor, Lipitor, Pravachol and Crestor to ward off heart attacks are more likely to develop Type 2 diabetes than those who do not take the widely used cholesterol-lowering drugs, a study has found. The report, published Monday in the Archives of Internal Medicine, showed that, in a large group of post-menopausal women, those who took a statin of any type were, on average, 48% likelier to develop Type 2 diabetes than those who didn’t.

Click here to read more…

FDA orders Crestor diabetes warning

In 2010, the Food and Drug Administration required the manufacturer of the cholesterol medication Crestor to issue a warning about the drug’s link to type 2 diabetes. Information about a link between Crestor and diabetes was added to the drug’s label in response to the FDA’s request.

Click here to read more…

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101


Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.